Andrew Daly

Calgary, AB, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications

Quality of Life and Comorbidities of Long-Term Survivors of Allogeneic Hematopoietic Cell Transplant Versus Their Siblings.

Quality of Life and Comorbidities of Long-Term Survivors of Allogeneic Hematopoietic Cell Transplant Versus Their Siblings.

Journal: Transplantation and cellular therapy
Published: September 27, 2025

Orthostatic Intolerance After Hematopoietic Stem Cell Transplantation: A Window Into Post-Transplant Autonomic Vulnerability.

Orthostatic Intolerance After Hematopoietic Stem Cell Transplantation: A Window Into Post-Transplant Autonomic Vulnerability.

Journal: JACC. CardioOncology
Published: May 12, 2025

Chronic liver disease after allogeneic hematopoietic cell transplantation.

Chronic liver disease after allogeneic hematopoietic cell transplantation.

Journal: Cytotherapy
Published: May 05, 2024

The Development of the Canadian Physiotherapy Assessment of Clinical Performance (ACP) 2.0 - Alignment with the 2017 Competency Profile.

The Development of the Canadian Physiotherapy Assessment of Clinical Performance (ACP) 2.0 - Alignment with the 2017 Competency Profile.

Journal: Physiotherapy Canada. Physiotherapie Canada
Published: March 11, 2024

Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.

Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.

Journal: Bone marrow transplantation
Published: January 26, 2024

Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.

Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.

Journal: Bone marrow transplantation
Published: August 24, 2023

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis.

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis.

Journal: Blood advances
Published: August 08, 2023

Corticosteroids as graft-versus-host disease prophylaxis for allogeneic hematopoietic cell transplant recipients with calcineurin inhibitor intolerance.

Corticosteroids as graft-versus-host disease prophylaxis for allogeneic hematopoietic cell transplant recipients with calcineurin inhibitor intolerance.

Journal: Cytotherapy
Published: January 04, 2023

Abstracts of the Cell Therapy Transplant Canada 2022 Annual Conference.

Abstracts of the Cell Therapy Transplant Canada 2022 Annual Conference.

Journal: Current oncology (Toronto, Ont.)
Published: November 26, 2022

Donor Genetic Predisposition to High Interleukin-10 Production Appears Protective against Acute Graft-Versus-Host Disease.

Donor Genetic Predisposition to High Interleukin-10 Production Appears Protective against Acute Graft-Versus-Host Disease.

Journal: International journal of molecular sciences
Published: November 17, 2022

Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation.

Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation.

Journal: Transplantation and cellular therapy
Published: August 03, 2021

Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysis.

Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysis.

Journal: Blood advances
Published: July 21, 2021
Showing 1-12 of 70

Last Updated: 09/26/2026